Dopamine antagonism and antischizophrenic potency of neuroleptic drugs.
D000661:Amphetamine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology* / Q000627:therapeutic use; D018492:Dopamine Antagonists; D006801:Humans; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D012559:Schizophrenia / Q000188:drug therapy; D013378:Substantia Nigra / Q000502:physiology; D013881:Thioridazine / Q000494:pharmacology* / Q000627:therapeutic use
D018492:Dopamine Antagonists; D000661:Amphetamine; D013881:Thioridazine; D002746:Chlorpromazine